Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225025 · ClinicalTrials.gov registry record · NA

A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT05225025 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05225025, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

This study is a pilot, single-center, randomized controlled trial. It will 1. determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit, 2. determine what adaptations may be needed for an inpatient population 3. determine what retention strategies are most successful and acceptable for this patient population 4. estimate the effect size of an intervention for in-hospital distress, anxiety and depression 5. estimate the effect size of an intervention to reduce the risk of a post-partum depression diagnosis or depressive symptoms.

Interventions

  • OTHER Standard of Care
  • BEHAVIORAL ROSE

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2021-07-05
Est. Completion 2022-05-02
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT05225025

The ClinicalTrials.gov registry entry for NCT05225025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT05225025 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05225025 about?

NCT05225025 is a clinical study titled "A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital". This study is a pilot, single-center, randomized controlled trial. It will 1. determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit, 2. determine what adaptations may be needed for an ...

What is the current status of trial NCT05225025?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-07-05. Estimated completion is 2022-05-02.

What interventions are being tested in trial NCT05225025?

The interventions under investigation include: Standard of Care (OTHER), ROSE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05225025?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.